Intensity-Modulated Radiation Therapy, Etoposide, and Cyclophosphamide Followed By Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
City of Hope Medical Center
City of Hope Medical Center
University of Chicago
Dana-Farber Cancer Institute
Institute of Hematology & Blood Diseases Hospital, China
Baylor College of Medicine
Goethe University
Astellas Pharma Inc
City of Hope Medical Center
Stanford University
Dana-Farber Cancer Institute
Thomas Jefferson University
University College, London
University of Pittsburgh
Children's Oncology Group
Arog Pharmaceuticals, Inc.
M.D. Anderson Cancer Center
Children's Oncology Group
M.D. Anderson Cancer Center
University of Nebraska
University of Nebraska
Arog Pharmaceuticals, Inc.
M.D. Anderson Cancer Center
Thomas Jefferson University
University of Nebraska
University of Nebraska
Alliance for Clinical Trials in Oncology
Therapeutic Advances in Childhood Leukemia Consortium
Emory University
University of Washington
Eastern Cooperative Oncology Group
Eastern Cooperative Oncology Group
Ohio State University Comprehensive Cancer Center
Goethe University
Gruppo Italiano Malattie EMatologiche dell'Adulto
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Goethe University
Goethe University
University of Washington
St. Jude Children's Research Hospital
University Hospital Schleswig-Holstein
Therapeutic Advances in Childhood Leukemia Consortium
Children's Oncology Group
Stanford University
National Institutes of Health Clinical Center (CC)
Roswell Park Cancer Institute
St. Jude Children's Research Hospital
Universität des Saarlandes
Roswell Park Cancer Institute
Children's Oncology Group